Cambridge UK: Uniqsis has launched the first instrument on the market for multi-kilogram flow chemistry. FlowSyn MAXI, allows users to safely perform larger-scale flow reactions, at up to 100ml/min between –90ºC and 260ºC, and at pressures up to 1400 psi.
One of the major benefits of flow chemistry is seamless scale-up without
re-optimisation. However, output has previously been limited to hundreds of grams per day. Now, with the innovative FlowSyn MAXI, users are producing many kilograms in a day by utilising high flow rate pumps and large-scale coil reactors up to 40ml, with temperature-controlled static mixers essential for some reactions.
The robust and versatile FlowSyn MAXI offers a choice of flowpath, including Teflon, stainless and Hastelloy – so pumping nitric acid, sulphuric acid, BuLi, and even concentrated HCl in the Hastelloy system, is possible.
For low-temperature exothermic chemistry, FlowSyn MAXI can be coupled with the FlowSyn Polar Bear. This advanced cooling module has no circulator fluid or messy insulated tubing and incredibly fast cooling rates allow the Polar Bear to reach –90ºC from room temperature in less than an hour.
Uniqsis Managing Director, Paul Pergande, said: ‘Following requests from customers to push the scale of flow chemistry, we adapted the highly successful FlowSyn for larger-scale chemistry. The FlowSyn MAXI is truly the first instrument on the market to deliver mg to kgs production, and when coupled with the FlowSyn Polar Bear can operate down to –90ºC to run those highly exothermic reactions.’
Visit www.uniqsis.com, e-mail [email protected], or call +44 (0)845 864 7747 for more information.
For product enquiries please contact:
Uniqsis
Paul Pergande +44 (0)845 864 7747
Email: [email protected]
For media enquiries please contact:
Phoenix MarCom Ltd
+ 44 (0) 1223 873318
Email: [email protected]
About Uniqsis Ltd
Based near Cambridge, UK, Uniqsis was formed in January 2007 by Asynt Ltd and Grant Instruments (Cambridge) Ltd to develop innovative continuous flow chemistry products for customers in both the research and biopharmaceutical sectors. A consortium of expert engineers, supporting companies and scientists from the pharmaceutical industry has been assembled to provide in-depth scientific and technical expertise to the development of this exciting new technology.